Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3220 results found

2024 ∙ Riemma, G. Etrusco, A. Laganà, A. S. Torella, M. Vastarella, M. G. Della Corte, L. D'Amato, A. La Verde, M. De Franciscis, P. Cobellis, L.

Susceptibility to Infection and Impact of COVID-19 Vaccines on Symptoms of Women with Endometriosis: A Systematic Review and Meta-Analysis of Available Evidence

  • Adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Low
2024 ∙ Wong, B. K. Mabbott, N. A.

Systematic review and meta-analysis of COVID-19 mRNA vaccine effectiveness against hospitalizations in adults

  • Adults
  • COVID-19
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Marra, F. Yip, M. Cragg, J. J. Vadlamudi, N. K.

Systematic review and meta-analysis of recombinant herpes zoster vaccine in immunocompromised populations

  • Adults
  • Older adults
  • Herpes zoster
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Levin, A. Yeung, K. H. T. Hutubessy, R.

Systematic review of cost projections of new vaccine introduction

  • All age groups
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Moradiya, P. Khandelwal, P. Raina, R. Mahajan, R. G.

Systematic Review of Individual Patient Data COVID-19 Infection and Vaccination-Associated Thrombotic Microangiopathy

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Williams, S. V. Akande, T. Abbas, K.

Systematic review of social determinants of childhood immunisation in low- and middle-income countries and equity impact analysis of childhood vaccination coverage in Nigeria

  • Africa
  • Nigeria
  • Newborn
  • Children
  • Low and Middle Income Countries
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Sahli, S. Stordal, K.

Systematic review of socioeconomic factors and COVID-19 in children and adolescents

  • Children
  • COVID-19
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Ardura-Garcia, C. Curtis, N. Zimmermann, P.

Systematic review of the impact of intestinal microbiota on vaccine responses

  • All age groups
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Cahuapaza-Gutierrez, N. L.

Systemic lupus erythematosus following COVID-19 vaccination. A systematic review of case reports and case series

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Li, C. Li, P. Peddibhotla, B. Teng, C. Shi, A. Lu, X. Cai, P. Dai, Q. Wang, B.

Takotsubo syndrome and vaccines: a systematic review

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Influenza
  • Safety
Methodological quality (AMSTAR 2):
Critically low
Loading...